Trump struck a deal with Pfizer to sell discounted drugs to Medicaid patients through a new federal site called TrumpRx. Pfizer will get a three-year exemption from upcoming pharma tariffs, offering discounts averaging 50%. Critics argue the program may not yield broad savings and warn tariffs could still push prices higher.
